PRIMARY STUDY

Effects of combined CBGA and cannabis-derived terpene nanoformulations on TRPV1 activation: Implications for enhanced pain management

Key Findings:  This study found that combining encapsulated cannabigerolic acid (CBGA) nanoparticles (NPs) with terpene-loaded NPs could enhance the pain-relieving properties of CBGA. These results present a promising novel strategy for advanced pain therapeutics.